289 related articles for article (PubMed ID: 26133385)
1. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition.
Sadaie M; Dillon C; Narita M; Young AR; Cairney CJ; Godwin LS; Torrance CJ; Bennett DC; Keith WN; Narita M
Mol Biol Cell; 2015 Sep; 26(17):2971-85. PubMed ID: 26133385
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
[TBL] [Abstract][Full Text] [Related]
3. The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects.
Li J; Yan Z; Li H; Shi Q; Ahire V; Zhang S; Nimishetti N; Yang D; Allen TD; Zhang J
J Nat Prod; 2021 Aug; 84(8):2312-2320. PubMed ID: 34406008
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibitor BMS-777607 induces breast cancer cell polyploidy with increased resistance to cytotoxic chemotherapy agents.
Sharma S; Zeng JY; Zhuang CM; Zhou YQ; Yao HP; Hu X; Zhang R; Wang MH
Mol Cancer Ther; 2013 May; 12(5):725-36. PubMed ID: 23468529
[TBL] [Abstract][Full Text] [Related]
5. Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
Bogen D; Wei JS; Azorsa DO; Ormanoglu P; Buehler E; Guha R; Keller JM; Mathews Griner LA; Ferrer M; Song YK; Liao H; Mendoza A; Gryder BE; Sindri S; He J; Wen X; Zhang S; Shern JF; Yohe ME; Taschner-Mandl S; Shohet JM; Thomas CJ; Martin SE; Ambros PF; Khan J
Oncotarget; 2015 Nov; 6(34):35247-62. PubMed ID: 26497213
[TBL] [Abstract][Full Text] [Related]
6. A small molecule identified through an in silico screen inhibits Aurora B-INCENP interaction.
Unsal E; Degirmenci B; Harmanda B; Erman B; Ozlu N
Chem Biol Drug Des; 2016 Dec; 88(6):783-794. PubMed ID: 27390292
[TBL] [Abstract][Full Text] [Related]
7. Selective disruption of aurora C kinase reveals distinct functions from aurora B kinase during meiosis in mouse oocytes.
Balboula AZ; Schindler K
PLoS Genet; 2014 Feb; 10(2):e1004194. PubMed ID: 24586209
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase inhibitor-2 balances protein phosphatase 1 and aurora B kinase for chromosome segregation and cytokinesis in human retinal epithelial cells.
Wang W; Stukenberg PT; Brautigan DL
Mol Biol Cell; 2008 Nov; 19(11):4852-62. PubMed ID: 18716057
[TBL] [Abstract][Full Text] [Related]
9. Switching of INCENP paralogs controls transitions in mitotic chromosomal passenger complex functions.
Feng H; Raasholm M; Moosmann A; Campsteijn C; Thompson EM
Cell Cycle; 2019 Sep; 18(17):2006-2025. PubMed ID: 31306061
[TBL] [Abstract][Full Text] [Related]
10. Genetic Interactions between the Aurora Kinases Reveal New Requirements for AURKB and AURKC during Oocyte Meiosis.
Nguyen AL; Drutovic D; Vazquez BN; El Yakoubi W; Gentilello AS; Malumbres M; Solc P; Schindler K
Curr Biol; 2018 Nov; 28(21):3458-3468.e5. PubMed ID: 30415701
[TBL] [Abstract][Full Text] [Related]
11. AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
Bertran-Alamillo J; Cattan V; Schoumacher M; Codony-Servat J; Giménez-Capitán A; Cantero F; Burbridge M; Rodríguez S; Teixidó C; Roman R; Castellví J; García-Román S; Codony-Servat C; Viteri S; Cardona AF; Karachaliou N; Rosell R; Molina-Vila MA
Nat Commun; 2019 Apr; 10(1):1812. PubMed ID: 31000705
[TBL] [Abstract][Full Text] [Related]
12. Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication.
De Santis Puzzonia M; Gonzalez L; Ascenzi S; Cundari E; Degrassi F
Cell Cycle; 2016; 15(2):274-82. PubMed ID: 26693937
[TBL] [Abstract][Full Text] [Related]
13. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo.
Faisal A; Vaughan L; Bavetsias V; Sun C; Atrash B; Avery S; Jamin Y; Robinson SP; Workman P; Blagg J; Raynaud FI; Eccles SA; Chesler L; Linardopoulos S
Mol Cancer Ther; 2011 Nov; 10(11):2115-23. PubMed ID: 21885865
[TBL] [Abstract][Full Text] [Related]
14. Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent-induced mitotic arrest.
Tsuda Y; Iimori M; Nakashima Y; Nakanishi R; Ando K; Ohgaki K; Kitao H; Saeki H; Oki E; Maehara Y
Sci Rep; 2017 Dec; 7(1):16762. PubMed ID: 29196757
[TBL] [Abstract][Full Text] [Related]
15. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah NA; Reddy MM
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Characterization of Derrone as an Aurora Kinase Inhibitor.
Hoang NT; Phuong TT; Nguyen TT; Tran YT; Nguyen AT; Nguyen TL; Bui KT
Biol Pharm Bull; 2016 Jun; 39(6):935-45. PubMed ID: 26983907
[TBL] [Abstract][Full Text] [Related]
17. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.
Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD
Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745
[TBL] [Abstract][Full Text] [Related]
18. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process.
Lordier L; Chang Y; Jalil A; Aurade F; Garçon L; Lécluse Y; Larbret F; Kawashima T; Kitamura T; Larghero J; Debili N; Vainchenker W
Blood; 2010 Sep; 116(13):2345-55. PubMed ID: 20548097
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells.
Noronha S; Alt LAC; Scimeca TE; Zarou O; Obrzut J; Zanotti B; Hayward EA; Pillai A; Mathur S; Rojas J; Salamah R; Chandar N; Fay MJ
In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):71-84. PubMed ID: 29197031
[TBL] [Abstract][Full Text] [Related]
20. Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.
Ghanizadeh-Vesali S; Zekri A; Zaker F; Zaghal A; Yousefi M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Ann Hematol; 2016 Jun; 95(7):1031-42. PubMed ID: 27091351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
